Daniel B. Carr, MD, FABPM
Professor of Anesthesiology and Medicine
Department of Anesthesia
Tufts Medical Center
Dr. Daniel Carr is the Saltonstall Professor of Pain Research in the Departments of Anesthesia and Medicine at Tufts Medical Center, Boston, and CMO of Javelin Pharmaceuticals, Cambridge, Massachusetts. He is known internationally for his contributions to pain research, evidence-based pain medicine, and to the social and political aspects of pain relief.
Dr. Carr co-chaired and drafted major portions of the Agency for Health Care Policy and Research Clinical Practice Guidelines on Acute and Cancer Pain Management. He was the principal technical consultant for the Agency for Healthcare Research and Quality evidence reports on cancer pain and symptom control; had leadership roles in the formation of comprehensive multidisciplinary pain treatment centers at the Massachusetts General Hospital, Tufts-New England Medical Center, and Caritas-St. Elizabeth’s Medical Center; and co-developed a novel outcomes instrument (“TOPS”) for patients with chronic pain.
In addition, Dr. Carr was the founding editor of the International Association for the Study of Pain's publication Pain: Clinical Updates, has been lead editor for pain trials in the Cochrane collaborative review group on Pain, Palliative and Supportive Care, and serves on the editorial boards of several pain-related journals. In addition to his work with AHCPR and AHRQ, he has had consultative or advisory board roles for the US Food and Drug Administration, the American Academy of Pain Medicine, the American Board of Pain Medicine, the American Pain Society, the International Association for the Study of Pain, the Joint Commission for the Accreditation of Healthcare Organizations, the National Institutes of Health Clinical Center Pain and Palliative Care Working Group, among others.